November 5, 2013

Alliance Boots GmbH, a leading international pharmacy-led health and beauty group, and Walgreen Co. (NYSE: WAG) (NASDAQ: WAG), the largest drugstore chain in the U.S., today announced that Richard Ashworth, Walgreens Corporate Operations Vice President for the Western United States, has been appointed as Director of Healthcare, Health & Beauty UK and Republic of Ireland (ROI) at Alliance Boots. He will report to Simon Roberts, Managing Director, Health & Beauty UK and ROI.

In this new role, Richard Ashworth will bring his extensive leadership and knowledge in healthcare and work in close collaboration with the experienced teams in both countries to lead the development and delivery of the Boots healthcare offer for customers in the UK and ROI.

Stefano Pessina, Executive Chairman of Alliance Boots, said: “We are very pleased to welcome Richard to our Group. His appointment further illustrates the progress we continue to make towards achieving our vision for the creation of the first global health and wellbeing enterprise. As he familiarises himself with the UK and Irish markets, Richard’s experience at Walgreens will bring positive benefits to Boots and the delivery of its healthcare plans, as well as help further combine best practices of our two companies.”

Greg Wasson, President and Chief Executive Officer of Walgreens, commented: “Richard’s two decades of healthcare experience, leadership and service to Walgreens in a variety of roles has been invaluable to our company as we continued to develop our strategy to transform community pharmacy. His move to Alliance Boots represents yet another step forward and is further testament to the strong and steady progress we are making in advancing our strategic partnership.”

Richard Ashworth’s appointment further contributes to the Alliance Boots and Walgreens strategic partnership, announced in June 2012, when the companies initiated a two-step process that would allow for the thoughtful integration of the two organisations. The convergence began at the end of 2012 with the establishment of a joint venture in Switzerland and the transition of key Walgreens and Alliance Boots executives to that entity, and continued with the appointment of Alex Gourlay, former Chief Executive of Alliance Boots Health & Beauty Division, as Walgreens Executive Vice President, President of Customer Experience and Daily Living, in August 2013.


Notes to Editors

Richard Ashworth

As Corporate Operations Vice President for Walgreens since 2011, Richard Ashworth, a pharmacist, led over 2,000 locations in the Western division, where he was primarily responsible for the overall development and growth of all drugstores and health care points of care. Joining the company in 1992 as a service clerk, he has held various store operations leadership positions from Pharmacy Supervisor to Market Vice President. He was promoted to Executive Vice President of Pharmacy Benefit Management services for Walgreens Health Initiatives, a subsidiary of Walgreens. In that role, he led sales and client services, clinical services and health outcomes, provider relations, and the operating teams. In 2010, Ashworth was promoted to Vice President of Pharmacy Operations, overseeing the clinical, operational and overall development of Walgreens pharmacies nationwide and implementation of pharmacy technology and services.

About Alliance Boots

Alliance Boots is a leading international, pharmacy-led health and beauty group delivering a range of products and services to customers. Working in close partnership with manufacturers and pharmacists, we are committed to improving health in the local communities we serve and helping our customers and patients to look and feel their best. Our focus is on growing our two core businesses: pharmacy-led health and beauty retailing and pharmaceutical wholesaling and distribution, while increasingly developing and internationalising our product brands.

Alliance Boots has a presence in more than 25* countries and employs over 108,000* people. Alliance Boots has pharmacy-led health and beauty retail businesses in nine* countries and operates more than 3,100* health and beauty retail stores, of which just over 3,000* have a pharmacy. In addition, Alliance Boots has around 605* optical practices, of which around 190* operate on a franchise basis, and around 390* hearingcare practices. Our pharmaceutical wholesale businesses deliver over 4.6 billion* units each year to more than 170,000* pharmacies, doctors, health centres and hospitals from over 370* distribution centres in 20* countries.

In June 2012, Alliance Boots announced that it had entered into a strategic partnership with Walgreen Co., the largest drugstore chain in the US, to create the first global pharmacy-led, health and wellbeing enterprise.

* Figures are approximations as at 31 March 2013 and include associates and joint ventures.

About Walgreens

As the nation's largest drugstore chain with fiscal 2012 sales of $72 billion, Walgreens ( vision is to be the first choice in health and daily living for everyone in America, and beyond. Each day, Walgreens provides more than 6 million customers the most convenient, multichannel access to consumer goods and services and trusted, cost-effective pharmacy, health and wellness services and advice in communities across America. Walgreens scope of pharmacy services includes retail, specialty, infusion, medical facility and mail service, along with respiratory services. These services improve health outcomes and lower costs for payers including employers, managed care organisations, health systems, pharmacy benefit managers and the public sector. The company operates 8,131 drugstores in all 50 states, the District of Columbia and Puerto Rico. Take Care Health Systems is a Walgreens subsidiary that is the largest and most comprehensive manager of worksite health and wellness centers and in-store convenient care clinics, with more than 700 locations throughout the country.


Alliance Boots

Investor Relations:
Gerald Gradwell +44 (0)207 980 8527 (UK), +1 646 688 1336 (US)

Media Relations:
Yves Romestan/Laura Vergani/Katie Johnson, +44 (0)207 980 8585
RLM Finsbury (London), James Murgatroyd/Claire Scicluna, +44 (0)207 251 3801


Investor Relations:

Rick Hans/Ashish Kohli, +1 847 315 2385/+1 847 315 3810

Media Relations:
Michael Polzin, +1 847 315 2920
Brunswick Group: Steve Lipin /Gemma Hart, +1 212 333 3810

Full press release as PDF - 5 November 2013

You must be logged in to view this item.

This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.